FDA Warning Letter Blasts Glenmark
Agency Says Firm Consistently Failed To Ensure ‘Effective, Safe’ Products
Glenmark, which has been the recipient of a string of notices from the US Food and Drug Administration over manufacturing quality issues, is again under fire with the regulator blasting the leading Indian drugmaker for failing to ensure “consistent production” of safe and effective products.
